Skip to main content
. 2021 Jul 20;64(15):10890–10899. doi: 10.1021/acs.jmedchem.1c00176

Figure 1.

Figure 1

Macrocyclic peptide antibiotics targeting the Gram-negative OM. (A) Structure of clinically used colistin; (B) structure of the protegrin I β-hairpin peptidomimetic murepavadin; (C) representative structure of recently reported chimeric antibiotics consisting of a β-hairpin mimetic ligated to the nonapeptide derived from colistin.